- Vital Therapies (NASDAQ:VTL): FY GAAP EPS of -$0.98 beats by $0.13.
- Cash and equivalents of $13.3M
- Press Release
- More news on: Vital Therapies, Inc., Earnings news and commentary, Healthcare stocks news, ,
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...